CIK: 1278271 - Address: 5600 Blazer Parkway, Suite 200, Dublin, OH 43017
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret216713206101412
P%wins83838350673367
S%ret11111-16-13-35-22-14
S%wins0010010010010067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/13/14 17:28
5/9/14
NAVBNavidea Biopharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticPykett Mark JeromeOHDOCEOP131.341103297D-51-412-18-23-18-12-12-1938-6-11-7
3/11/14 17:21
3/10/14
NAVBNavidea Biopharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticPykett Mark JeromeOHDOCEOS-2351.962-120-30287D-28-38-301518571011-16-13-35-22
11/8/13 11:46
11/8/13
NAVBNavidea Biopharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticPykett Mark JeromeOHDOCEOP151.353113407D-49-44-43-52-48-36-30-299631252-13
3/18/13 14:57
3/15/13
NAVBNavidea Biopharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticPykett Mark JeromeOHDOP,CEOP52.70621358D-16-161-7-20-11-14-224-40-48-23
9/14/12 10:41
9/11/12
NAVBNavidea Biopharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticPykett Mark JeromeOHDOP,CEOP112.64741310D35-15-17-12-27-31-30-24619-2848
8/23/11 08:08
8/22/11
NEOPNeoprobe CorpDEHealthMdEqSurgical & Medical InstrumentPykett Mark JeromeOHDOP,CEOP112.6004New4M
4/15/08 17:11
5/24/04
ANXAdventrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsPykett Mark JeromeCADP12.080178D-90-80-3415-20-2-10-6092-23-55-62
4/7/05 14:28
4/6/05
ANXAdventrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsPykett Mark JeromeMADP51.7003New3D274-45076833924421404938112180

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact